{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:29:53Z","timestamp":1790666993964,"version":"4.1.0"},"reference-count":35,"publisher":"Impact Journals, LLC","issue":"40","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,10,4]]},"DOI":"10.18632\/oncotarget.11623","type":"journal-article","created":{"date-parts":[[2016,8,26]],"date-time":"2016-08-26T03:58:40Z","timestamp":1472183920000},"page":"64649-64664","source":"Crossref","is-referenced-by-count":118,"title":["FGF23 promotes myocardial fibrosis in mice through activation of \u03b2-catenin"],"prefix":"10.18632","volume":"7","author":[{"given":"Huixin","family":"Hao","sequence":"first","affiliation":[{"name":"State Key Laboratory of Organ Failure Research, Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixian","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Organ Failure Research, Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingman","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Organ Failure Research, Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hairuo","family":"Lin","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Organ Failure Research, Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhuan","family":"Chen","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Organ Failure Research, Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahe","family":"Xie","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Organ Failure Research, Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanling","family":"Xuan","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Organ Failure Research, Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangjun","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Bin","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Organ Failure Research, Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Huang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Organ Failure Research, Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Kitakaze","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Organ Failure Research, Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, China"},{"name":"Cardiovascular Division of the Department of Medicine, National Cerebral and Cardiovascular Center, Fujishirodai, Suita, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Liao","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Organ Failure Research, Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,8,25]]},"reference":[{"issue":"9","key":"1","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.yexcr.2012.02.027","article-title":"Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease","volume":"318","author":"Quarles","year":"2012","journal-title":"Exp Cell Res"},{"key":"2","first-page":"247","article-title":"Pathophysiological roles of FGF signaling in the heart","volume":"4","author":"Ohta","year":"2013","journal-title":"Front Physiol"},{"issue":"6","key":"3","article-title":"[FGF23 and the heart]","volume":"31","author":"Kovesdy","year":"2014","journal-title":"G Ital Nefrol"},{"issue":"4","key":"4","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/MNH.0b013e32836213ee","article-title":"FGF23 and Klotho in chronic kidney disease","volume":"22","author":"Larsson","year":"2013","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"9","key":"5","doi-asserted-by":"crossref","first-page":"e44161","DOI":"10.1371\/journal.pone.0044161","article-title":"A comparative transcriptome analysis identifying FGF23 regulated genes in the kidney of a mouse CKD model","volume":"7","author":"Quarles","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"6","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.atherosclerosis.2009.05.013","article-title":"Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population","volume":"207","author":"Larsson","year":"2009","journal-title":"Atherosclerosis"},{"issue":"4","key":"7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/MNH.0b013e32835422c4","article-title":"Fibroblast growth factor 23 and the heart","volume":"21","author":"Faul","year":"2012","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"11","key":"8","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Chen","year":"2011","journal-title":"J Clin Invest"},{"issue":"19","key":"9","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease","volume":"119","author":"Wolf","year":"2009","journal-title":"Circulation"},{"issue":"5","key":"10","article-title":"Chronic sustained inflammation links to left ventricular hypertrophy and aortic valve sclerosis: a new link between S100\/RAGE and FGF23","volume":"1","author":"Bowman","year":"2014","journal-title":"Inflamm Cell Signal"},{"issue":"5","key":"11","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1681\/ASN.2012080865","article-title":"Loss of Klotho contributes to kidney injury by derepression of Wnt\/beta-catenin signaling","volume":"24","author":"Liu","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"12","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/clc.22404","article-title":"Increased Transforming Growth Factor-beta Levels Associated With Cardiac Adverse Events in Hypertrophic Cardiomyopathy","volume":"38","author":"Dinckal","year":"2015","journal-title":"Clin Cardiol"},{"issue":"11","key":"13","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1253\/circj.CJ-14-0511","article-title":"Enhanced bioactive myocardial transforming growth factor-beta in advanced human heart failure","volume":"78","author":"Tsuda","year":"2014","journal-title":"Circ J"},{"issue":"39","key":"14","doi-asserted-by":"crossref","first-page":"27199","DOI":"10.1074\/jbc.M114.580977","article-title":"Deficiency of cardiomyocyte-specific microRNA-378 contributes to the development of cardiac fibrosis involving a transforming growth factor beta (TGFbeta1)-dependent paracrine mechanism","volume":"289","author":"Gupta","year":"2014","journal-title":"J Biol Chem"},{"issue":"4","key":"15","first-page":"337","article-title":"Wnt\/beta-catenin signaling: a promising new target for fibrosis diseases","volume":"61","author":"Liu","year":"2012","journal-title":"Physiol Res"},{"issue":"6","key":"16","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/BOR.0b013e32834b3309","article-title":"beta-catenin signaling: a novel mediator of fibrosis and potential therapeutic target","volume":"23","author":"Gottardi","year":"2011","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"17","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/cvr\/cvr221","article-title":"Detrimental effect of fractalkine on myocardial ischaemia and heart failure","volume":"92","author":"Kitakaze","year":"2011","journal-title":"Cardiovasc Res"},{"issue":"11","key":"18","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1097\/CCM.0b013e31825fd7da","article-title":"Resveratrol improves myocardial ischemia and ischemic heart failure in mice by antagonizing the detrimental effects of fractalkine","volume":"40","author":"Liao","year":"2012","journal-title":"Crit Care Med"},{"issue":"6","key":"19","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.cmet.2015.09.002","article-title":"Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy","volume":"22","author":"Mayer","year":"2015","journal-title":"Cell Metab"},{"issue":"10","key":"20","doi-asserted-by":"crossref","first-page":"640","DOI":"10.7326\/0003-4819-152-10-201005180-00004","article-title":"The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study","volume":"152","author":"Ix","year":"2010","journal-title":"Ann Intern Med"},{"issue":"1","key":"21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/CIRCULATIONAHA.114.013876","article-title":"Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial","volume":"132","author":"Floege","year":"2015","journal-title":"Circulation"},{"issue":"10","key":"22","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/jbmr.2527","article-title":"Experimental Myocardial Infarction Upregulates Circulating Fibroblast Growth Factor-23","volume":"30","author":"Erben","year":"2015","journal-title":"J Bone Miner Res"},{"key":"23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.yjmcc.2015.06.010","article-title":"CB1 cannabinoid receptor antagonist attenuates left ventricular hypertrophy and Akt-mediated cardiac fibrosis in experimental uremia","volume":"85","author":"Shih","year":"2015","journal-title":"J Mol Cell Cardiol"},{"issue":"9","key":"24","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1097\/HJH.0b013e3282170ada","article-title":"Myocardial fibrosis and diastolic dysfunction in patients with hypertension: results from the Swedish Irbesartan Left Ventricular Hypertrophy InvestigationAtenolol (SILVHIA)","volume":"25","author":"Malmqvist","year":"2007","journal-title":"J Hypertens"},{"issue":"24","key":"25","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1093\/eurheartj\/ehr246","article-title":"Deficiency of type 1 cannabinoid receptors worsens acute heart failure induced by pressure overload in mice","volume":"33","author":"Kitakaze","year":"2012","journal-title":"Eur Heart J"},{"issue":"1","key":"26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/kisup.2014.16","article-title":"Wnt\/beta-catenin signaling and kidney fibrosis","volume":"4","author":"Liu","year":"2014","journal-title":"Kidney Int Suppl (2011)"},{"issue":"2","key":"27","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/emboj.2011.418","article-title":"Wnt1\/betacatenin injury response activates the epicardium and cardiac fibroblasts to promote cardiac repair","volume":"31","author":"Deb","year":"2012","journal-title":"Embo j"},{"issue":"11","key":"28","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1093\/ndt\/gfu190","article-title":"Treatment of established left ventricular hypertrophy with fibroblast growth factor receptor blockade in an animal model of CKD","volume":"29","author":"Brand","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"29","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1111\/jcmm.12399","article-title":"HMGB1 mediates hyperglycaemia-induced cardiomyocyte apoptosisERK\/Ets-1 signalling pathway","volume":"18","author":"Zhang","year":"2014","journal-title":"J Cell Mol Med"},{"issue":"17","key":"30","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1161\/CIRCULATIONAHA.114.013789","article-title":"Myocardial Hypertrophic Preconditioning Attenuates Cardiomyocyte Hypertrophy and Slows Progression to Heart Failure Through Upregulation of S100A8\/A9","volume":"131","author":"Liao","year":"2015","journal-title":"Circulation"},{"issue":"7","key":"31","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1042\/CS20130716","article-title":"Disruption of histamine H2 receptor slows heart failure progression through reducing myocardial apoptosis and fibrosis","volume":"127","author":"Liao","year":"2014","journal-title":"Clin Sci (Lond)"},{"issue":"3","key":"32","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s00395-013-0342-4","article-title":"Histamine H2 receptor activation exacerbates myocardial ischemia\/reperfusion injury by disturbing mitochondrial and endothelial function","volume":"108","author":"Liao","year":"2013","journal-title":"Basic Res Cardiol"},{"issue":"10","key":"33","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1042\/CS20140586","article-title":"Overexpression of ankyrin repeat domain 1 enhances cardiomyocyte apoptosis by promoting p53 activation and mitochondrial dysfunction in rodents","volume":"128","author":"Liao","year":"2015","journal-title":"Clin Sci (Lond)"},{"issue":"22","key":"34","doi-asserted-by":"publisher","first-page":"18829","DOI":"10.18632\/oncotarget.4774","article-title":"Inhibition of microRNA-497 ameliorates anoxia\/reoxygenation injury in cardiomyocytes by suppressing cell apoptosis and enhancing autophagy","volume":"6","author":"Liao","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"35","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.bbrc.2015.06.117","article-title":"Ablation of C\/EBP homologous protein increases the acute phase mortality and doesn\u2019t attenuate cardiac remodeling in mice with myocardial infarction","volume":"464","author":"Liao","year":"2015","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11623","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T13:23:40Z","timestamp":1589289820000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,25]]},"references-count":35,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2016,10,4]]}},"alternative-id":["11623","27579618"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.11623","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,25]]}}}